$Acquired mutations in patients with relapsed/refractory CLL who progressed in the ALPINE study$

Acquired mutations in patients with relapsed/refractory CLL who progressed in the ALPINE study

Abstract: Some patients with chronic lymphocytic leukemia who develop progressive disease (PD) during covalent Bruton tyrosine kinase (BTK) inhibitor treatment acquire resistance mutations in BTK or PLCG2. Here, we report gene mutation data from paired baseline and PD peripheral blood samples from 5...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jennifer R. Brown, Jessica Li, Barbara F. Eichhorst, Nicole Lamanna, Susan M. O’Brien, Constantine S. Tam, Lugui Qiu, Ruiqi Huang, Yang Shi, Adam Idoine, Tommi Salmi, Aileen Cleary Cohen, Mazyar Shadman
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	Blood Advances
Online Access:	http://www.sciencedirect.com/science/article/pii/S2473952925000473
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Acquired mutations in patients with relapsed/refractory CLL who progressed in the ALPINE study

Similar Items